Click it and Unblock the Notifications
Just In
Don't Miss
-
Varshangalkku Shesham Box Office Collection: Vineeth Sreenivasan's Film Shines; Makes Over Rs 50 Crore -
1:6 Split: Metal Giant Vedanta Shares Hit New 52-Week High On Big Announcement; Splitting Up By Dec-2024 -
IIT Madras Introduces International master's course on Water Security and Global Change -
Realme C65 Reportedly Launching Soon in India - Check Expected Price & Specs -
Why is Dhanashree Verma not attending IPL 2024 matches of husband Yuzvendra Chahal? -
Kerala Spearheads Revival of Iconic Double-Decker Trains in India -
These Common Habits Can Be Insidious, Can Hurt Any Partner And Ruin Any Relationship -
From Coconut Breaking on Head to Men Dressing as Women: 12 Unique Indian Rituals Explored
Glenmark markets, distributes 5 dermatology products in US
New Delhi, Mar 17 (UNI) Drugmaker Glenmark Pharmaceuticals Ltd today said its US arm Glenmark Pharmaceuticals Inc (GPI) has commenced marketing and distribution of five Clobetasol Propionate dermatology products in the US market.
The firm is also planning to launch an additional 11 dermatological products in the next one year.
It has acquired the US marketing rights for a line of Clobetasol Propionate products, including Cream, E Cream, Ointment Gel and Topical Solution through a US-based pharmaceutical development company, a statement said.
Clobetasol Propionate is used to treat diseases like eczema and psoriasis, and it is also dispensed to counter auto-immune diseases.
The total sales for the five products for the year ending December 2007 was above 28 million dollars, the statement added.
Based on these recent launches, GPI now has a portfolio of 28 generic products for the US market.
UNI
SG
SBA
ND1250
